...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: bid- .0451/144 ask- .22/3,687???????????...

bid- .0451/144

ask- .22/3,687

pathetic -  hard working & full of excitment ,no. Doing nothing & full of bs while raping both companies of funds. How can these people justify their wage??

any body heard anything true this year? How about the rumor mill, whats the score there?

0-0 & down 13+ %

doing a great job of either giving it away or trying to steal i

Share
New Message
Please login to post a reply